Litcius/Paper detail

Scientific journey to the first FDA-approved drug for eosinophilic esophagitis

Marc E. Rothenberg

2022Journal of Allergy and Clinical Immunology22 citationsDOIOpen Access PDF

Topics & Concepts

Eosinophilic esophagitisEosinophiliaMedicineEsophagitisEndotypeProton-pump inhibitorImmunologyNerdDupilumabDiseaseInternal medicineRefluxGERDAsthmaEosinophilic EsophagitisEosinophilic Disorders and SyndromesIL-33, ST2, and ILC Pathways
Scientific journey to the first FDA-approved drug for eosinophilic esophagitis | Litcius